We focus on the discovery of prognostic and predictive biomarkers in prostate cancer, the investigation of mechanisms that mediate tumor progression, and the development of novel therapeutic strategies that target disease drivers. Our team is comprised of biologists and computational scientists working together to advance our understanding of cancer biology with the aim of improving patient outcomes.